L Sagnard
Overview
Explore the profile of L Sagnard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cadroy Y, Bossavy J, Thalamas C, Sagnard L, Sakariassen K, Boneu B
Circulation
. 2000 Jun;
101(24):2823-8.
PMID: 10859288
Background: We conducted a double-blind, randomized, crossover study to assess the antithrombotic effects of the combination of aspirin (acetylsalicylic acid, ASA) and clopidogrel, with or without a loading dose, versus...
2.
Meignan M, Rosso J, Gauthier H, Brunengo F, Claudel S, Sagnard L, et al.
Arch Intern Med
. 2000 Jan;
160(2):159-64.
PMID: 10647753
Background: A high frequency of asymptomatic pulmonary embolism (PE) has been reported in patients with deep venous thrombosis (DVT) in studies of a limited number of patients using varying criteria...
3.
Urban P, Macaya C, Rupprecht H, Kiemeneij F, Emanuelsson H, Fontanelli A, et al.
Circulation
. 1998 Nov;
98(20):2126-32.
PMID: 9815866
Background: Although the association of ticlopidine and aspirin has been shown to be superior to anti-vitamin K agents and aspirin after coronary stent implantation in low-risk patients, the latter combination...
4.
Bossavy J, Thalamas C, Sagnard L, Barret A, Sakariassen K, Boneu B, et al.
Blood
. 1998 Aug;
92(5):1518-25.
PMID: 9716578
No randomized study comparing the effect of combined ticlopidine and aspirin therapy versus each drug alone in reducing poststenting thrombotic complications has been performed. To compare these three antiplatelet regimens...
5.
Charbonnier B, Fiessinger J, Banga J, Wenzel E, dAzemar P, Sagnard L
Thromb Haemost
. 1998 Jun;
79(5):897-901.
PMID: 9609216
Background: Clinical trials have been performed to compare with standard heparin a once or a twice daily regimen of low-molecular-weight heparin but no direct comparison has been done between these...
6.
Chatelain P, Job J, Blanchard J, Ducret J, Oliver M, Sagnard L
J Clin Endocrinol Metab
. 1994 Jun;
78(6):1454-60.
PMID: 8200949
This study reports the results of a 2-yr clinical trial with GH in 95 short prepubertal children with non-GH-deficient intrauterine growth retardation. This randomized, double blind, controlled study compared the...
7.
ROMER T, Rymkiewicz-Kluczynska B, Olivier M, Sagnard L, Szarras-Czapnik M
J Clin Endocrinol Metab
. 1991 Feb;
72(2):503-6.
PMID: 1991817
Twenty severely GH-deficient prepubertal children aged 10.7 +/- 2.1 yr (mean +/- SD) and with a height SD of -4.92 +/- 1.02 were treated with sc injections of GHRH 1-44...
8.
Job J, Chatelain P, Rochiccioli P, Ponte C, Olivier M, Sagnard L
Horm Res
. 1990 Jan;
33(5):161-5.
PMID: 2272607
The release of growth hormone (GH) during the 120 min following a bolus venous injection of 1-44 GH-releasing hormone (GHRH) 2 micrograms/kg was studied in 52 prepubertal children aged 8.4...
9.
Colle M, Sagnard L, Ducret J, Auzerie J
Horm Res
. 1990 Jan;
34(5-6):204-8.
PMID: 2100276
In order to investigate the value of growth hormone (GH) treatment during late puberty, we studied the effect of human GH (hGH) administration (0.85 +/- 0.30 IU/kg/week; range: 0.44-1.28) on...